National Research (NRC) Competitors $11.52 +0.04 (+0.35%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$11.52 0.00 (0.00%) As of 10/14/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRC vs. IIIV, YEXT, PRSU, MEG, EEX, EVH, NVRI, AHG, FVRR, and NRDSShould you be buying National Research stock or one of its competitors? The main competitors of National Research include i3 Verticals (IIIV), Yext (YEXT), Pursuit Attractions and Hospitality (PRSU), Montrose Environmental Group (MEG), Emerald (EEX), Evolent Health (EVH), Enviri (NVRI), Akso Health Group (AHG), Fiverr International (FVRR), and NerdWallet (NRDS). These companies are all part of the "business services" industry. National Research vs. Its Competitors i3 Verticals Yext Pursuit Attractions and Hospitality Montrose Environmental Group Emerald Evolent Health Enviri Akso Health Group Fiverr International NerdWallet i3 Verticals (NASDAQ:IIIV) and National Research (NASDAQ:NRC) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation. Is IIIV or NRC more profitable? i3 Verticals has a net margin of 55.87% compared to National Research's net margin of 12.78%. National Research's return on equity of 83.52% beat i3 Verticals' return on equity.Company Net Margins Return on Equity Return on Assets i3 Verticals55.87% 3.87% 2.91% National Research 12.78%83.52%18.05% Does the media prefer IIIV or NRC? In the previous week, i3 Verticals and i3 Verticals both had 5 articles in the media. National Research's average media sentiment score of 0.89 beat i3 Verticals' score of 0.88 indicating that National Research is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment i3 Verticals 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National Research 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, IIIV or NRC? i3 Verticals has higher revenue and earnings than National Research. i3 Verticals is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioi3 Verticals$229.92M4.44$113.34M$5.226.06National Research$143.06M1.86$24.78M$0.7615.16 Do analysts recommend IIIV or NRC? i3 Verticals currently has a consensus price target of $34.33, indicating a potential upside of 8.48%. Given i3 Verticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe i3 Verticals is more favorable than National Research.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score i3 Verticals 1 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50National Research 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has more volatility & risk, IIIV or NRC? i3 Verticals has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, National Research has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Do institutionals and insiders believe in IIIV or NRC? 84.2% of i3 Verticals shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 59.1% of i3 Verticals shares are owned by company insiders. Comparatively, 2.0% of National Research shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Summaryi3 Verticals beats National Research on 11 of the 15 factors compared between the two stocks. Get National Research News Delivered to You Automatically Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRC vs. The Competition Export to ExcelMetricNational ResearchBUSINESS INFO SVC IndustryBusiness SectorNASDAQ ExchangeMarket Cap$264.77M$19.47B$31.64B$10.51BDividend Yield4.18%1.67%2.93%4.80%P/E Ratio15.1666.2326.5427.24Price / Sales1.863.78955.55200.41Price / Cash8.6016.9331.1661.53Price / Book8.4734.448.316.74Net Income$24.78M$558.69M$196.57M$276.59M7 Day Performance-3.36%-2.45%-0.50%-0.47%1 Month Performance-28.89%-9.94%4.91%7.47%1 Year Performance-40.74%-11.24%56.51%34.58% National Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRCNational Research2.2714 of 5 stars$11.52+0.3%N/A-39.5%$264.77M$143.06M15.16490Analyst ForecastIIIVi3 Verticals4.3928 of 5 stars$32.92-0.4%$34.33+4.3%+41.4%$1.07B$248.27M6.311,480YEXTYext1.8695 of 5 stars$8.41-0.1%$9.44+12.2%+20.8%$1.04B$449.66M-70.081,150PRSUPursuit Attractions and Hospitality2.1197 of 5 stars$36.42+2.0%$29.67-18.5%N/A$1.01B$366.49M3.151,500Positive NewsMEGMontrose Environmental Group2.6988 of 5 stars$28.35-0.1%$32.50+14.6%+27.7%$1.00B$780.12M-18.773,410Analyst ForecastEEXEmerald1.8375 of 5 stars$4.86-1.2%$7.95+63.6%+19.0%$974.03M$432.60M97.20600EVHEvolent Health1.96 of 5 stars$8.26+0.4%$17.21+108.4%-71.5%$967.10M$2.55B-5.134,500NVRIEnviri0.2072 of 5 stars$11.80-1.4%$10.00-15.3%+17.8%$965.36M$2.34B-6.0212,000AHGAkso Health Group0.5092 of 5 stars$1.57-1.9%N/A+57.9%$882.98M$14.78M0.0040Positive NewsGap DownFVRRFiverr International3.7456 of 5 stars$24.08+2.6%$32.60+35.4%-1.5%$841.26M$419.13M50.17790NRDSNerdWallet3.7104 of 5 stars$10.95-0.7%$13.60+24.2%-11.0%$838.28M$687.60M17.66770Positive NewsGap Down Related Companies and Tools Related Companies IIIV Alternatives YEXT Alternatives PRSU Alternatives MEG Alternatives EEX Alternatives EVH Alternatives NVRI Alternatives AHG Alternatives FVRR Alternatives NRDS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRC) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
